Ticker
$SRXH
1 catalyst touching SRXH in the last 60 days, newest first, each with the price move that followed.
- 72
SRX Global to acquire CERo Therapeutics for stock and ~$9.8M debt forgiveness
SRX Global signed a definitive agreement to acquire CERo Therapeutics' operating subsidiary from its parent CERo Therapeutics Holdings, with consideration consisting of $1M in SRXH stock (at lower of prior-day close or 20-day VWAP), forgiveness of $8.25M in outstanding debt plus accrued interest, and assumption of ~$1.56M in liabilities. The transaction is subject to a 30-day go-shop period and superior proposal rights, creating execution risk through at least mid-March 2027.
SRXH ·SEC 8-K · 7 Oct 2026, 12:05 UTC
Information only. AURA does not give buy or sell recommendations.